Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Coppens

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Thrombosis Journal|May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Research and Practice in Thrombosis and Haemostasis|May 1, 2024
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and BTine M H J Goedhart, Laura H Bukkems, Anne-Fleur Zwagemaker, et al.
BMJ Open|August 28, 2025
Improving outcome in SubaraChnoid HEMorrhage wIth nAdroparin (ISCHEMIA): a prospective randomised controlled trial protocolNadine Denneman, Tom C Doorschodt, Bert A Coert, et al.
Journal of Thrombosis and Haemostasis : JTH|December 10, 2019
Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiencyIvar van Asten, Maaike Blaauwgeers, Lianne Granneman, et al.
Blood Advances|May 9, 2022
The bleeding phenotype in people with nonsevere hemophiliaFabienne R Kloosterman, Anne-Fleur Zwagemaker, Catherine N Bagot, et al.
Journal of the American Heart Association|May 25, 2021
CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) Trial: Long-Term Follow-Up ResultsPascale Notten, André A E A de Smet, Lidwine W Tick, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2021
Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control studyAmal Abdi, Corien L Eckhardt, Alice S van Velzen, et al.
Emergency Medicine Journal : EMJ|November 7, 2022
Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS StudyRoisin Bavalia, Milou A M Stals, Frits I Mulder, et al.
Research and Practice in Thrombosis and Haemostasis|December 6, 2021
Hepatitis C virus in hemophilia: Health-related quality of life after successful treatment in the sixth Hemophilia in the Netherlands studyCas J Isfordink, Samantha C Gouw, Erna C van Balen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and BAnne-Fleur Zwagemaker, Fabienne R Kloosterman, Samantha C Gouw, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Thrombosis Journal|May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Research and Practice in Thrombosis and Haemostasis|May 1, 2024
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and BTine M H J Goedhart, Laura H Bukkems, Anne-Fleur Zwagemaker, et al.
BMJ Open|August 28, 2025
Improving outcome in SubaraChnoid HEMorrhage wIth nAdroparin (ISCHEMIA): a prospective randomised controlled trial protocolNadine Denneman, Tom C Doorschodt, Bert A Coert, et al.
Journal of Thrombosis and Haemostasis : JTH|December 10, 2019
Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiencyIvar van Asten, Maaike Blaauwgeers, Lianne Granneman, et al.
Blood Advances|May 9, 2022
The bleeding phenotype in people with nonsevere hemophiliaFabienne R Kloosterman, Anne-Fleur Zwagemaker, Catherine N Bagot, et al.
Journal of the American Heart Association|May 25, 2021
CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) Trial: Long-Term Follow-Up ResultsPascale Notten, André A E A de Smet, Lidwine W Tick, et al.
Journal of Thrombosis and Haemostasis : JTH|June 9, 2021
Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control studyAmal Abdi, Corien L Eckhardt, Alice S van Velzen, et al.
Emergency Medicine Journal : EMJ|November 7, 2022
Use of the National Early Warning Score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS StudyRoisin Bavalia, Milou A M Stals, Frits I Mulder, et al.
Research and Practice in Thrombosis and Haemostasis|December 6, 2021
Hepatitis C virus in hemophilia: Health-related quality of life after successful treatment in the sixth Hemophilia in the Netherlands studyCas J Isfordink, Samantha C Gouw, Erna C van Balen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Little discrepancy between one-stage and chromogenic factor VIII (FVIII)/IX assays in a large international cohort of persons with nonsevere hemophilia A and BAnne-Fleur Zwagemaker, Fabienne R Kloosterman, Samantha C Gouw, et al.
Pageof 15